Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
3,720,405
-
Share change
-
-1,334,494
-
Total reported value
-
$98,524,254
-
Price per share
-
$26.39
-
Number of holders
-
18
-
Value change
-
-$12,681,796
-
Number of buys
-
12
-
Number of sells
-
9
Institutional Holders of BIOTIE THERAPIES OYJ - SPONSORED ADR (BITI) as of Q1 2016
As of 31 Mar 2016,
BIOTIE THERAPIES OYJ - SPONSORED ADR (BITI) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,720,405 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, Vivo Capital, LLC, ORBIMED ADVISORS LLC, Versant Venture Management, LLC, MORGAN STANLEY, K2 PRINCIPAL FUND, L.P., CREDIT SUISSE AG/, GLG Partners LP, Cormorant Asset Management, LLC, and GLG LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.